PUBLICATIONS

1. Bagchi A, Nath A, Thamodaran V, Ijee S, Palani D, Rajendiran V, Venkatesan V, Datari P, Pai A , Janet N, Balasubramanian P, Nakamura Y, Srivastava A, Murugesan Mohankumar, Thangavel S and Velayudhan S. Direct Generation of Immortalized Erythroid Progenitor Cell Lines from Peripheral Blood Mononuclear Cells. Cells. 2021 March. DOI: 10.3390/cells10030523

2. Venkatesan V, Srinivasan S, Babu P and Thangavel S. Manipulation of Developmental Gamma-Globin Gene Expression: an Approach for Healing Hemoglobinopathies. Mol Cell Biol. 2020 Dec21;41(1):e00253-20. DOI: 10.1128/MCB.00253-20

3. Daniel HDJ, Kumar S, Kannangai R, Lakshmi KM, Agbandje-McKenna M, Coleman KE, Srivastava A, Srivastava A, Abraham AM. Prevalence of AAV3 capsid binding and neutralizing antibodies in healthy and individuals with hemophilia B from India. Hum Gene Ther.2020 Nov 18. DOI: 10.1089/hum.2020.258

4. Harrison C. Brown, Christopher B. Doering, Roland W. Herzog, Chen Ling, David M. Markusic, H. Trent Spencer, Alok Srivastava, and Arun Srivastava. Development of a Clinical Candidate AAV3 Vector for Gene Therapy of Hemophilia B. Hum Gene Ther. 2020 Jul. DOI: 10.1089/hum.2020.099

5. Doering CB, Denning G, Shields JE, Fine EJ, Parker ET, Srivastava A, Lollar P, Spencer HT. Preclinical Development of a Hematopoietic Stem and Progenitor Cell Bioengineered Factor VIII Lentiviral Vector Gene Therapy for Hemophilia A. Hum Gene Ther. 2018 Oct;29(10):1183-1201. DOI: 10.1089/hum.2018.137

6. Devaraju D, Rajendiran V, Ravi NS and Mohankumar KM. Genome engineering of hematopoietic stem cells using CRISPR-Cas9 system. Methods in Molecular Biology

sfgrsgrgrgrt